jab-21822
jacobio pharmaceuticals
['jab-21822']
jacobio announces phase i clinical data of kras g12c inhibitor jab-21822 at 2022 asco annual meeting #stocksmarket #pressrelease
Join us at https://t.co/9QZSYoqhvl - Stock Market News and Press Releases. #StockMarket - As an affiliate, we earn from qualifying purchases.